Brain Implants Market Overview, Challenges and Growth Opportunities Analysis till 2028

Posted on 2022-09-12 by researchinsights in Healthcare // 0 Comments

San Francisco, California , USA, Sept 12, 2022 — /EPR Network/ —

Brain Implants Industry Overview

The global brain implants market size was valued at USD 4.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2021 to 2028. Increasing incidence of neurological conditions such as Parkinson’s disease, Alzheimer’s, and epilepsy, coupled with increasing awareness regarding brain implant benefits, and positive research outcomes are among the major factors driving the growth of the overall market.

The increasing prevalence of neurological disorders is a high-impact rendering driver for the market. For instance, according to the WHO, neurological diseases contribute 6.3% to the global disease burden and are one of the major causes of mortality worldwide, resulting in 13.2% deaths in developed countries and 16.8% in low- and middle-income countries. This has created clinical urgency for the incorporation of long-term solutions such as spinal cord stimulators and deep brain stimulators. Moreover, the global prevalence of stress and obesity-induced depression is constantly increasing. As per the National Institute of Mental Health (NIHM), in 2016, 16.2 million adults had been through at least one major depressive episode in the U.S. Brain implants have been proved to play a crucial role in providing therapeutic solutions for depression. Thus, a rise in the prevalence of such diseases is expected to drive market growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Brain Implants market

Moreover, the growing global geriatric population and increase in the incidence of target diseases, especially Parkinson’s, epilepsy, and Alzheimer’s, as well as high unmet medical needs has increased the demand for brain implants. The growing base of the aging population is more prone to Parkinson’s disease. Individuals suffering from Parkinson’s are not able to release adequate dopamine in the brain, which leads to walking problems, tremors, and stiffness, among other conditions. As per the CDC, Parkinson’s disease is largely diagnosed in people over the age of 60 and it is projected that it affects 1.0% of the population over 60 to 4.0% by age 80. According to the WHO 2018 report, the population pertaining to the age group of 60 and above is expected to reach approximately 2 billion by 2050, from 900 million in 2015. Thus, the geriatric population is highly susceptible to PD, which is expected to be a key factor driving the market for brain implants.

Furthermore, the introduction of advanced technologies such as MRI safety-enabled brain implants by Medtronic and the launch of transdermal neuromodulation technology (introduced by Neurowave Medical Technologies) is further anticipated to drive the market. In addition, technologies such as motor neuron prostheses, microelectrode arrays, and Brain Computer Interfaces (BCIs) exhibit benefits such as improved patient mobility profile. This advancement acts as a high-impact-rendering driver for the market. For instance, smart neural chips improve the wireless transmission of brain signals into fingers and hands with around 95% accuracy and this is anticipated to upsurge the demand for brain implants during the forecast period.

Countries such as the U.S. and Canada have witnessed a high prevalence rate of movement and psychiatric disorders coupled with an increasing geriatric population in the region. In addition, an increase in government funding and initiatives for raising awareness about movement disorders are expected to drive the demand for brain implants. For instance, in 2020, Parkinson’s Foundation invested USD 3.5 million to fund more than 34 research projects for Parkinson’s disease. Similarly, According to Epilepsy Canada, 0.6% of the Canadian population is affected by epilepsy. Every year, around 15,500 people learn that they have epilepsy. Moreover, approximately 2% of the population has obsessive-compulsive disorder, according to the Canadian Psychological Association. These factors are expected to boost the demand for brain implants in these countries.

Furthermore, the increasing number of research activities leading to technological breakthroughs is expected to witness lucrative growth opportunities in the market for brain implants. These include self-charging implants and memory chips that are anticipated to provide the market with growth opportunities over the forecast period. For instance, Andersen Lab has research on cognitive signals in Post Parietal Cortex (PPC) for decoding target position for motions. The signals received by the cortex are used for controlling the device. Additionally, potential benefits of these devices, such as better management of postoperative outcomes and long-term efficacy are expected to facilitate market growth over the forecast period. These key factors are anticipated to raise the demand for brain implants.

The lockdown and restrictions pertaining to preventing the spread of COVID-19 in 2020 have had a significant impact on both the patients who have scheduled surgery and those who already undergone the DBS surgery. Brain implant surgery such as DBS is an elective surgical procedure in several institutes due to which the scheduled surgeries have been put on hold. Patients were advised to continue their last optimized dose regimen and surgeries were performed when the restrictions were lifted. Thus, the outbreak of COVID-19 has resulted in low demand for brain implants, therefore restraining market growth.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Hormonal Contraceptive Market – The global hormonal contraceptive market size was valued at USD 16.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.29% over the forecast period.
Health Sensors Market – The global health sensors market size was valued at USD 41.18 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 18.53% from 2022 to 2030.

Brain Implants Market Segmentation

Grand View Research has segmented the global brain implants market on the basis of product, application, and region:

Brain Implants Product Outlook (Revenue, USD Million, 2016 – 2028)
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Vagus Nerve Stimulator
Brain Implants Application Outlook (Revenue, USD Million, 2016 – 2028)
- Chronic Pain
- Epilepsy
- Parkinson’s Disease
- Depression
- Essential Tremor
- Alzheimer’s Disease
Brain Implants Regional Outlook (Revenue, USD Million, 2016 – 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Brain Implants market include

Medtronic
Boston Scientific Corporation
St. Jude Medical (Abbott)
NeuroPace, Inc.
Nevro Corporation
Synapse Biomedical Inc.
Aleva Neurotherapeutics SA

Order a free sample PDF of the Brain Implants Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Matched content

Editor’s pick